PMV PHARMACEUTICALS INC. - COMMON STOCK
1.6400
01-November-24 12:07:06
15 minutes delayed
Stocks
+0.0100
+0.61%
Today's range
1.6200 - 1.6400
ISIN
N/A
Source
NASDAQ
-
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
23 Oct 2024 08:00:01 By Nasdaq GlobeNewswire
-
08 Aug 2024 08:00:01 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
30 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
29 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
09 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
18 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
29 Feb 2024 16:01:00 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
26 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
18 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
05 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
09 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 12:30:00 By Nasdaq GlobeNewswire
-
20 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights
09 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference
06 Jun 2023 16:01:00 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights
10 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights
01 Mar 2023 08:00:02 By Nasdaq GlobeNewswire
-
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March
28 Feb 2023 16:05:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >